To assess whether HIF1α and its transcriptional target genes contributed to Sorafenib resistance, we first identified the HIF1α target genes highly expressed in Sorafenib-resistant HCC cells (Fig. 1b). The gene discussed is HIF1A; the disease is hepatocellular carcinoma.